Resultados de búsqueda - Heyerdahl, Helen
- Mostrando 1 - 7 Resultados de 7
-
1
Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting (227)Th-DOTA-p-benzyl-trastuzumab por Heyerdahl, Helen, Abbas, Nasir, Brevik, Ellen Mengshoel, Mollatt, Camilla, Dahle, Jostein
Publicado 2012Texto -
2
-
3
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate (212)Pb-NNV003 por Maaland, Astri Fjelde, Saidi, Amal, Torgue, Julien, Heyerdahl, Helen, Stallons, Tania A. Rozgaja, Kolstad, Arne, Dahle, Jostein
Publicado 2020Texto -
4
Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003 por Maaland, Astri Fjelde, Heyerdahl, Helen, O’Shea, Adam, Eiriksdottir, Bergthora, Pascal, Véronique, Andersen, Jan Terje, Kolstad, Arne, Dahle, Jostein
Publicado 2019Texto -
5
(89)Zr-PET imaging to predict tumor uptake of (177)Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma por Giesen, Danique, Hooge, Marjolijn N. Lub-de, Nijland, Marcel, Heyerdahl, Helen, Dahle, Jostein, de Vries, Elisabeth G. E., Pool, Martin
Publicado 2022Texto -
6
Anti-CD37 radioimmunotherapy with (177)Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin’s lymphoma in vitro por Malenge, Marion M., Maaland, Astri Fjelde, Repetto-Llamazares, Ada, Middleton, Brian, Nijland, Marcel, Visser, Lydia, Patzke, Sebastian, Heyerdahl, Helen, Kolstad, Arne, Stokke, Trond, Ree, Anne Hansen, Dahle, Jostein
Publicado 2022Texto -
7
The therapeutic effectiveness of (177)Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest por Pichard, Alexandre, Marcatili, Sara, Karam, Jihad, Constanzo, Julie, Ladjohounlou, Riad, Courteau, Alan, Jarlier, Marta, Bonnefoy, Nathalie, Patzke, Sebastian, Stenberg, Vilde, Coopman, Peter, Cartron, Guillaume, Navarro-Teulon, Isabelle, Repetto-Llamazares, Ada, Heyerdahl, Helen, Dahle, Jostein, Bardiès, Manuel, Pouget, Jean-Pierre
Publicado 2019Texto